Fmr LLC Lexicon Pharmaceuticals, Inc. Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Fmr LLC holds 34,543,197 shares of LXRX stock, worth $22.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,543,197

Previous 51,970,455 33.53%

Holding current value

$22.1 Million

Previous $38.5 Million 58.68%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$0.29 - $0.96 $5.05 Million - $16.7 Million	-17,427,258 Reduced 33.53%	34,543,197 $15.9 Million
Q4 2024 Feb 13, 2025	BUY	$0.65 - $2.08 $1.37 Million - $4.38 Million	2,103,413 Added 4.22%	51,970,455 $38.5 Million
Q3 2024 Nov 13, 2024	BUY	$1.51 - $2.39 $16.9 Million - $26.7 Million	11,179,919 Added 28.9%	49,867,042 $78.3 Million
Q2 2024 Aug 13, 2024	BUY	$1.54 - $2.28 $38.2 Million - $56.5 Million	24,793,061 Added 178.44%	38,687,123 $65 Million
Q1 2024 May 13, 2024	BUY	$1.3 - $3.58 $15.1 Million - $41.6 Million	11,617,594 Added 510.33%	13,894,062 $33.3 Million
Q4 2023 Feb 13, 2024	SELL	$1.0 - $1.53 $5.29 Million - $8.09 Million	-5,286,608 Reduced 69.9%	2,276,468 $3.48 Million
Q3 2023 Nov 13, 2023	SELL	$1.06 - $2.33 $1 Million - $2.21 Million	-947,992 Reduced 11.14%	7,563,076 $8.24 Million
Q2 2023 Aug 11, 2023	BUY	$2.15 - $3.49 $7.03 Million - $11.4 Million	3,270,821 Added 62.42%	8,511,068 $19.5 Million
Q1 2023 May 11, 2023	SELL	$1.99 - $2.68 $22,761 - $30,653	-11,438 Reduced 0.22%	5,240,247 $12.7 Million
Q4 2022 Feb 13, 2023	SELL	$1.8 - $2.56 $56,365 - $80,163	-31,314 Reduced 0.59%	5,251,685 $10 Million
Q3 2022 Nov 10, 2022	SELL	$1.94 - $3.43 $14,773 - $26,119	-7,615 Reduced 0.14%	5,282,999 $12.7 Million
Q2 2022 Aug 12, 2022	BUY	$1.31 - $2.69 $85 - $174	65 Added 0.0%	5,290,614 $9.84 Million
Q1 2022 May 13, 2022	SELL	$1.95 - $3.89 $736,298 - $1.47 Million	-377,589 Reduced 6.66%	5,290,549 $11.1 Million
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $3.02 Million - $4.89 Million	-793,218 Reduced 12.28%	5,668,138 $22.3 Million
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $3.3 Million - $5.22 Million	-975,157 Reduced 13.11%	6,461,356 $31.1 Million
Q2 2021 Aug 13, 2021	BUY	$4.12 - $5.87 $30.6 Million - $43.7 Million	7,436,513 New	7,436,513 $34.1 Million

Others Institutions Holding LXRX

# of Institutions

135

Shares Held

196M

Call Options Held

310K

Put Options Held

77.3K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $121M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account